SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as its community grapples with mixed sentiments amidst ongoing price stagnation, despite some believing a potential merger involving Zero Hash and Mastercard, alongside progress on the Clarity Act, could be catalysts. Many holders are expressing frustration over consistent declines, while others are actively accumulating, pointing to Flexa's real-world utility with major merchants and recent patents as reasons for long-term optimism. The debate rages between those who see it as a foundational payment collateral token and those who fear it's a 'dead project' that continually disappoints.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing highly polarized sentiment, with many in the community expressing frustration over significant losses and year-end tax-loss selling contributing to downward pressure. Despite widespread discussions questioning its utility and sustained underperformance relative to other major cryptocurrencies, a dedicated segment of holders maintains long-term conviction, eagerly anticipating a future resurgence.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending with a massive volume surge and price rally following news of a strategic manufacturing partnership aimed at scaling production of its drug screening reader for future U.S. market entry. The community is intensely divided, with bulls pointing to the low float and the positive impact of a $10 million private placement on its balance sheet, while bears express significant concern over dilution, the company's reverse split history, and the offering's terms.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to massive trading volume and a significant price surge, sparking intense community discussion around its low-float SPAC nature. Traders are actively anticipating further upward movement and a potential squeeze, drawing parallels to other recently explosive micro-cap plays that have experienced rapid ascents.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is generating significant buzz as a low-float SPAC, with traders actively discussing its potential for a substantial price run. The community is drawing strong parallels to recent 'shell company rippers' like ESHA, anticipating a considerable upward movement fueled by limited circulating shares and growing speculative interest.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to its new integration with a Stripe-owned fiat anchor, which enables seamless, compliant bank-to-stablecoin transfers at a verified 11 million transactions per second. The community sees it as a potentially undervalued Layer 1 blockchain, poised to become essential financial infrastructure for institutions by offering high-speed, regulated settlement rails. This focus on enterprise-grade plumbing for global finance differentiates it from many other crypto projects.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant upward momentum as the FDA granted Priority Review for its AXS-05 in Alzheimer's disease agitation, with a PDUFA target date of April 30, and confirmed a clear path for its AXS-12 narcolepsy treatment. This major regulatory progress, alongside robust Auvelity sales growth and numerous analyst price target increases, has ignited strong bullish sentiment across the community. Many are celebrating long-term holdings and are optimistic about Axsome's potential to capitalize on substantial market opportunities in CNS disorders.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending with significant community anticipation for the start of a new yearly cycle, driving strong bullish sentiment for substantial long-term gains. Many investors are actively accumulating, citing historical patterns that suggest an imminent upward trajectory. The discussion is marked by strong convictions from bulls, despite ongoing skepticism from bears regarding its immediate outlook.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending amid intense community debate, primarily driven by widespread shareholder frustration with CEO Richard Paulson and the board, whom many accuse of continuous value destruction and mismanagement. Recent financing and a reverse stock split, while extending the cash runway, have amplified concerns about dilution and executive accountability. Despite this pervasive negative sentiment toward leadership, significant bullish options activity and anticipation for upcoming Phase 3 trial readouts in Myelofibrosis and Endometrial Cancer highlight an underlying belief in the company's scientific potential, contingent on a change in management.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent strategic moves, including pipeline expansion through acquisitions and manufacturing advancements for its lead anticoagulant candidate, Tecarfarin. The market is weighing the potential of these developments, including analyst-assigned price targets and FDA designations, against community concerns about cash burn, dilution, and the company's ability to fund pivotal Phase 3 trials. This creates a polarized discussion, highlighting the high-stakes nature of micro-cap biopharma investments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)?

<ul><li>Citi noted that while the company’s bookings jumped 85% in the third quarter, revenue was impacted by supply constraints and data center delays.</li><li>CoreWeave joined the DOE-backed Genesis Mission on Thursday.</li><li>It plans to make its purpose-built AI cloud platform available for advanced scientific workloads.</li></ul>CoreWeave Inc (CRWV) stock rose more than 17% on Friday amid Wall Street optimism and the company’s participation in the Department of Energy’s (DOE) Genesis Mission, which provides AI cloud support for scientific research.<a href="https://stocktwits.com/symbol/CRWV">CRWV</a> was among the top trending tickers on Stocktwits at the time of writing.<h2 class="st-heading-2">Citi Resumes Coverage</h2>Citi resumed coverage of the stock with a ‘Buy’ rating but cut its target price to $135 from $192, following a period of restriction, according to The Fly. This still represents a 70% upside from the current stock price of $79.Citi highlighted an 85% quarter-over-quarter surge in bookings in the third quarter, while noting that revenue was held back in the near term by supply constraints and delays in activating new power and data center capacity. The firm said demand remains strong and expects capacity to stay on track through the fourth quarter.<h2 class="st-heading-2">DOE’s Genesis Mission</h2>On Thursday, CoreWeave joined the Genesis Mission, a program that connects research institutions, supercomputing centers, and AI platforms to improve access to advanced computing resources and large-scale datasets.As part of the effort, CoreWeave plans to make its purpose-built AI cloud platform available for advanced scientific workloads.Earlier this year, the company launched CoreWeave Federal, a unit focused on providing secure AI cloud services to U.S. government agencies and defense partners. The platform is being prepared to meet federal requirements, including FedRAMP authorization, to support large-scale AI workloads.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits shifted to ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘high’ message volumes. One user sounded bullish on the stock as they believe a double bottom pattern has been confirmed.<stembedurl>https://stocktwits.com/MomentusTradus/message/639688926</stembedurl>However, another user suggested a profit-booking opportunity.<stembedurl>https://stocktwits.com/Veechj/message/639688614</stembedurl>On Friday, CRWV stock recorded its biggest intraday gain since September 10. However, the stock has been under selling pressure lately, declining more than 36% over the past three months.CoreWeave operates 41 data centers, including eight that came online in the third quarter. The footprint represents about 90 megawatts of active power and roughly 2.9 gigawatts of contracted power, according to an S&amp;P report earlier this month.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/amicus-stock-surges-to-near-2-year-highs-on-bio-marin-s-4-8-b-buyout-deal/cLeiUBwREsk">Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of AI cloud-computing startup CoreWeave is displayed on a smartphone screen on May 16, 2025 in Suqian, Jiangsu Province of China. 

Why Did CoreWeave Stock Surge Over 17% Today?

Citi resumed coverage of the stock with a ‘Buy’ rating but cut its target price to $135 from $192.

Equity

 ETFs to Buy as Broadcom Trips 11% Despite Beating Q4 Earnings & Revenues

AVGO slid 11% after Q4 results despite beating on earnings and revenues, as concerns over AI margins weighed on sentiment, making ETFs like SMH a safer way to play the dip.

The Zacks Analyst Blog Highlights IYW, FTEC, AIQ, FDN, XT and BOTZ

AI-rich valuations spark caution, but strong Mag 7 earnings keep tech ETFs like IYW, FTEC, AIQ, FDN, XT and BOTZ in focus.

AI Valuations Rich, But Strong Earnings a Plus: ETFs in Focus

AI stocks stay elevated as FOMO drives momentum, but strong earnings ease bubble worries. Here's why risks remain -- and the ETFs best positioned to benefit.

<ul class="summary-bullets"><li>Microsoft reported its second Microsoft 365 outage in less than a month, disrupting Teams for Education.</li><li>The issue prevented users from opening or loading assignments and grades.</li><li>The company is restarting backend systems and implementing configuration changes to resolve the problem.</li></ul>Microsoft (MSFT) reported a second major disruption in less than a month to its Microsoft 365 platform, affecting users of Teams for Education across Europe on Wednesday.&nbsp;According to Microsoft’s support account on X, the issue has prevented administrators and other users from opening or loading assignments and grades in Microsoft Teams for Education. “Any user with a Microsoft Teams Educational account may be unable to open or load assignments and grades,” the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/MSFT365Status/status/1988560064433516943">wrote,</a> directing affected users to the admin center for updates.<figure class="image"><a class="st-link-external" href="https://x.com/MSFT365Status/" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:820/266;" src="https://news.stocktwits-cdn.com/MSFT_1_jpg_0f2b6570a3.webp" alt="MSFT1.jpg" width="820" height="266"></a><figcaption>@MSFT365Status/X</figcaption></figure><a href="http://stocktwits.com/symbol/MSFT">MSFT’s stock</a> edged 0.3% in pre-market trade with retail sentiment around the software giant trending in ‘neutral’ territory over the past day.Microsoft said it is restarting certain backend infrastructure components that power Teams services to try and mitigate the impact. In its latest&nbsp;update, the company stated that while the issue was initially identified among administrators, it has now affected a broader group of users.Microsoft did not provide a timeline for full restoration, but said updates would be communicated through the Microsoft 365 admin center.<figure class="image"><a class="st-link-external" href="https://x.com/MSFT365Status/" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:820/542;" src="https://news.stocktwits-cdn.com/MSFT_2_jpg_5afbed59da.webp" alt="MSFT2.jpg" width="820" height="542"></a><figcaption>@MSFT365Status/X</figcaption></figure>The outage comes less than a month after a previous&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/microsoft-hit-by-azure-office-365-service-disruptions-ahead-of-q3-results/cLGZMHUR3wU">service disruption&nbsp;</a>on October 29, which latest nearly eight hours and was caused by a configuration error in Azure Front Door (AFD) – Microsoft’s content delivery network service. The issue highlights persistent reliability risks for businesses and educational institutions heavily dependent on Microsoft 365’s collaboration and productivity tools, especially Teams.&nbsp;In its latest update, Microsoft&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/MSFT365Status/status/1988623718566772790?s=20">said</a> its making a configuration change to resolve the issue that was preventing us from connecting additional backend infrastructure to the affected service and mitigating user impact.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jim-cramer-says-the-year-of-magical-investing-is-ending/cLPIu0JRE5o">Jim Cramer Says The ‘Year of Magical Investing’ Is Ending – ‘Too Much OpenAI IOUs Flying Around’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Microsoft office building is in the RheinauArtOffice in Cologne, Germany, on September 11, 2025. (Photo by Michael Nguyen/NurPhoto via Getty Images)

Second Microsoft Outage In A Month Disrupts Teams Access Across Europe 

Microsoft did not provide a timeline for full restoration, but said updates would be communicated through the Microsoft 365 admin center.

<ul class="summary-bullets"><li>Pagaya is expected to report fiscal year 2025 third-quarter adjusted earnings per share (EPS) of $0.21 and revenue of $338.35 million.</li><li>A recent Moody’s report warned about the complexity of the company’s financial reporting.</li><li>The stock has gained more than 145% this year.</li></ul>Pagaya Technologies Ltd. (PGY) shares elicited brisk retail chatter on Stocktwits early Monday as retail traders discussed the company’s quarterly results, which are due to be released before the market opens. The Israeli company, based in Tel Aviv and New York, is a fintech platform that focuses on subprime U.S. consumers, utilizing artificial intelligence (AI) technology to analyze loans.<a href="https://stocktwits.com/symbol/PGY">Pagaya stock</a> has gained more than 145% this year. In the overnight hours, the stock jumped over 7%, according to Yahoo Finance.<h2 class="st-heading-2">Retail Optimism Grows</h2>Retail sentiment toward the small-cap Pagaya among users of the Stocktwits platform remained ‘neutral’ as of early Monday, and the message volume was also ‘normal.A bullish watcher said the Senate vote on the government shutdown could not have come at a better moment. The user predicted a short-squeeze if the earnings are good.<stembedurl>https://stocktwits.com/Cerberus59/message/635555621</stembedurl>The short interest in the stock is at 15.50%, the highest on record. The company went public in June 2022 through a Special Purpose Acquisition Company (SPAC) route.<img src="https://news.stocktwits-cdn.com/Pagaya_Tech_short_interest_png_dd0bf59ddd.webp" alt="Pagaya Tech_short_interest.png">Source: KoyfinAnother user said they expected revenue to be normal but flagged write-offs and bad loans as the most important issue. “Analysts will be examining this closely,” they said.<stembedurl>https://stocktwits.com/bullenkuh/message/635555036</stembedurl>But some also have apprehensions about the valuation, with a user stating that the stock is still “too overpriced.”<stembedurl>https://stocktwits.com/nyamsamb/message/635201875</stembedurl><h2 class="st-heading-2">What Analysts Expect From Pagaya's Q3</h2>According to Stocktwits&nbsp;data, Pagaya is expected to report fiscal year 2025 third-quarter adjusted earnings per share (EPS) of $0.21 and revenue of $338.35 million. In early August, the company guided to third-quarter revenue of $330 million to $350 million.For the full year, the company expects revenue to be between $1.25 billion and $1.325 billion, and net income to be between $55 million and $75 million.&nbsp;Earlier this month, Pagaya said it had clinched a new forward flow agreement with Castlelake, an alternative asset management firm specializing in asset-based private credit, for the purchase of up to $500 million of auto loans sourced through its platform. The company also announced several asset-backed securities (ABS) deals.&nbsp;In early October, the company announced that it had expanded its revolving credit facility with top-tier banks, with the enhanced amount now at $132 million. The larger facility was negotiated with a 400-basis-point reduction in the interest rate.<h2 class="st-heading-2">Asset Quality Under Scrutiny</h2>A Bloomberg report&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/newsletters/2025-11-08/ai-powered-lender-pagaya-ignites-more-subprime-lending-worries">said</a> Pagaya’s ABS issuance faces&nbsp;its&nbsp;most significant test as U.S. consumers come under increasing strain. Despite management's assurance that it has tightened risk management, a recent Moody’s report warned about the complexity of the company’s financial reporting. The firm also flagged “a lack of reporting of securitization asset quality metrics such as problem loan and net charge-off ratios.”For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sound-hound-retail-traders-incredibly-bullish-amid-deal-traction/cLPc7fHREcV">SoundHound Retail Traders ‘Incredibly Bullish’ Amid Deal Traction — Can Stock Rebound From 37% YTD Loss?</a>

 In this photo illustration, the Pagaya Technologies logo is seen displayed on a smartphone screen. 

Pagaya’s Retail Traders Brace For Q3 Results As Short Interest Surges To Record High — Fintech's Asset Quality In Focus

 Pagaya investors hold a mixed view of the stock ahead of the fintech company’s quarterly results.

Pagaya’s Retail Traders Brace For Q3 Results As Short Interest Surges To Record High 

 Pagaya investors hold a mixed view of the stock ahead of the fintech company’s quarterly results.


AI Supercharger: Why Is NVDA-ORCL-DOE Deal a Bull Signal for Tech ETFs?

Nvidia and Oracle's DOE-backed AI supercomputer project fuels optimism for tech ETFs, like TRFK and XLK, poised to ride the next wave of AI growth.  

With Strong Holiday Outlook for iPhones, Can Apple ETFs Gain Ahead? 

Apple's strong iPhone 17 demand and upbeat holiday outlook could favor Apple-heavy ETFs like FTEC, IYW and VGT. But slowing China sales and rich valuations are a drag.

ETFs to Buy as Microsoft's Shares Slide Despite Q1 Earnings Beat 

MSFT's Q1 earnings beat and rising AI demand make ETFs, like IYW and XLK, with heavy MSFT exposure, a timely opportunity. 

FTEC
Fidelity MSCI Information Technology Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest FTEC News

FTECFidelity MSCI Information Technology Index ETF